Clinical Trials Logo

Mortality clinical trials

View clinical trials related to Mortality.

Filter by:

NCT ID: NCT04149873 Completed - Mortality Clinical Trials

Effectness of Treatment With Mechanical Insufflation-Exsufflation

Start date: September 2015
Phase: N/A
Study type: Interventional

Patients defined with impaired cough function as maximum expiratory pressure (MEP) < 60cmH2O. Collected the patients in our surgical ICU who are able to reach 6-8CC/IBW under pressure support mode for 24 hours and MEP < 60cmH2O. Then the patients will be allocated to 3 groups to receive (1) conventional CPT (control group) (2) MI-E (study group A) (3) MI-E plus CPT (study group B) until 48 hours after extubation. Reintubation rates, ICU mortality and post-extubation ICU length of stay will be analyzed to evaluate its effects.

NCT ID: NCT04092465 Completed - Mortality Clinical Trials

Outcomes of Surgical Resection After Induction Treatment in Non-Small Cell Lung Cancer (SRaIT)

SRaIT
Start date: September 30, 2011
Phase:
Study type: Observational

Surgery still remains the main treatment option for Non-Small Cell Lung Cancer (NSCLC) which is limited within the lung parenchyma and possibly invades the intrapulmonary or hilar nodes. The role of surgery in locally advanced NSCLC with the form of invasion of adjacent strictures or mediastinal nodes is a 30-year point of discussion and debate among thoracic surgeons, clinical and radiation oncologists, chest physicians and other related specialties. Despite the continuous debate the management of locally advanced NSCLC varies between different countries and different institutions.We try to investigate the short and long term outcomes of surgery after induction treatment performed for locally advanced NSCLC.

NCT ID: NCT04032288 Completed - Mortality Clinical Trials

Establish a Prospective Registration System of ARDS Patients for Improving Quality of Care

Start date: October 11, 2012
Phase:
Study type: Observational

The registration system will enroll and follow up ARDS patients prospectively through screening patients with bilateral radiographic infiltrates and a PaO2/FiO2 ratio of 200 mmHg or less by respiratory therapist. The diagnosis of ARDS must be made by an intensivist or chest physician. Including characteristics, co-morbidities, clinical features, laboratory data, organs dysfunction, treatments and outcomes of ARDS patients will be recorded.

NCT ID: NCT03930160 Completed - Mortality Clinical Trials

LODS Role in Predicting 30-day Mortality Outcome in ICU

Start date: May 17, 2018
Phase:
Study type: Observational

LODS score for deceased ICU patients within 30 days is higher than survived ICU patients

NCT ID: NCT03885206 Completed - Quality of Life Clinical Trials

Effectiveness and Clinical Outcomes of Municipal Acute Wards Versus a General Hospital

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

Demographic changes in the industrialized world are expected to prompt a need for better organized and more efficient health care services. In order to curb costs, health care providers in many countries are searching for viable alternatives to hospitalizations. Norwegian white papers and reform documents presume that the municipalities will play a central role in meeting the growth in demand for health services. Central public policy documents and national research strategies highlight that we need pathways characterized by good quality and safe care, and which are responsive to needs, based on user involvement, continuity of care and successful collaboration within and between service levels. The 2012 Coordination Reform placed new responsibilities on municipalities in the delivery of primary health care services and on hospitals as deliverers of specialist services, as well as on the integration and collaboration between the two organizational levels. This reform mandates that all 428 Norwegian municipalities are obliged to establish or co-operate on establishing Municipal Acute Wards (MAW) (In Norwegian: Kommunale akutte døgnplasser), so as to alleviate pressure on hospitals. However, the research basis for these units is relatively weak. Hence, there is little information on the outcomes regarding the quality, cost-effectiveness, patient-reported as well as personnel-reported outcomes of this new level of care. This study aims at assessing the outcome of admissions to MAWs compared to a general hospital for patients in need of acute care, that can be treated at a lower and decentralized level of health care, with potentially less resources than traditional hospitalizations. The study will use a Randomized Controlled Trial (RCT) design. It builds on previous research and systematic reviews, and aims to assess several outcomes, including health-related quality of life (HRQoL), patient experiences, cost-effectiveness, short-term mortality and morbidity, and draws on linkages to national registers.

NCT ID: NCT03749122 Completed - Surgery Clinical Trials

Time to Hip Fracture Surgery

Start date: January 1, 2006
Phase:
Study type: Observational

The purpose of the study is to evaluate how time from hospital admission to start of surgery influence mortality in patients with acute hip fracture. Data on patients with hip fracture surgery will be collected from the hospital's registration system and will be analyzed regarding age, gender, American Society of Anesthesiologists (ASA) Physical Status Classification, type of surgery and time from admission to surgery along with data on mortality.

NCT ID: NCT03436472 Completed - Delirium Clinical Trials

Dexmedetomidine and 5-year Outcome in Elderly Patients After Surgery

Start date: June 1, 2017
Phase: N/A
Study type: Interventional

Delirium is a frequent postoperative complication. Its occurrence is associated with worse long-term outcomes. In a previous randomized controlled trial, prophylactic low-dose dexmedetomidine infusion during the early postoperative period decreased the incidence of delirium in elderly patients after surgery. The purpose of this 5-year follow-up study is to evaluate whether prophylactic low-dose dexmedetomidine infusion can improve the 5-year outcomes in elderly patients recruited in the previous randomized controlled trial.

NCT ID: NCT03382730 Completed - Mortality Clinical Trials

De-adoption of Oral Chlorhexidine Prophylaxis and Implementation of an Oral Care Bundle (CHORAL)

CHORAL
Start date: December 1, 2017
Phase: N/A
Study type: Interventional

The objective of the CHORAL study is to evaluate the de-adoption of oral chlorhexidine and the introduction of a bundle of oral care practices on selected outcomes in critically ill mechanically ventilated adults.

NCT ID: NCT03378843 Completed - Mortality Clinical Trials

Spermidine Intake and All-cause Mortality

Start date: October 1995
Phase: N/A
Study type: Observational

This study seeks to test the potential association between spermidine content in diet and mortality in humans.

NCT ID: NCT03364582 Completed - Colorectal Cancer Clinical Trials

Dietary Patterns, Metabolomics and Colorectal Cancer Risk

Start date: June 1, 2016
Phase:
Study type: Observational

Colorectal cancer (CRC) is the third most commonly diagnosed cancer in American men and women with ≥130,000 new cases each year. Several dietary patterns have been associated with CRC risk but underlying mechanisms are not fully understood. Researchers thus propose to integrate dietary patterns and metabolomics data to comprehensively investigate biological pathways linking dietary patterns and CRC risk.